These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24224012)

  • 41. Aberrant GSTP1 promoter methylation predicts short-term prognosis in acute-on-chronic hepatitis B liver failure.
    Gao S; Sun FK; Fan YC; Shi CH; Zhang ZH; Wang LY; Wang K
    Aliment Pharmacol Ther; 2015 Aug; 42(3):319-29. PubMed ID: 26040771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
    Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
    Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation.
    Li K; Qin L; Jiang S; Li A; Zhang C; Liu G; Sun J; Sun H; Zhao Y; Li N; Zhang Y
    Clin Epigenetics; 2020 Jun; 12(1):81. PubMed ID: 32513305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T; Sari O; Koc Y; Eren N; Isleem M; Kara E; Sevinc M; Sakaci T; Ahbap E; Hasbal NB; Bayrakdar Caglayan F; Unsal A
    Minerva Urol Nefrol; 2017 Jun; 69(3):307-312. PubMed ID: 27768023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shear wave elastography in the evaluation of renal parenchymal stiffness in patients with chronic kidney disease.
    Leong SS; Wong JHD; Md Shah MN; Vijayananthan A; Jalalonmuhali M; Ng KH
    Br J Radiol; 2018 Sep; 91(1089):20180235. PubMed ID: 29869920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease.
    Dai Z; Zhu J; Huang H; Fang L; Lin Y; Huang S; Xie F; Sheng N; Liang X
    Nephrology (Carlton); 2020 May; 25(5):398-405. PubMed ID: 31412142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases.
    Sun L; Li K; Liu G; Xu Y; Zhang A; Lin D; Zhang H; Zhao X; Jin B; Li N; Zhang Y
    Cancer Med; 2018 Oct; 7(10):5178-5186. PubMed ID: 30259695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telomerase activity in patients with stage 2-5D chronic kidney disease.
    Kidir V; Aynali A; Altuntas A; Inal S; Aridogan B; Sezer MT
    Nefrologia; 2017; 37(6):592-597. PubMed ID: 28705647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
    Yuan G; Niu L; Zhang Y; Wang X; Ma K; Yin H; Dai J; Zhou W; Pan Y
    J Neurooncol; 2017 May; 133(1):193-201. PubMed ID: 28516344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis.
    Cao YH; Lv LL; Zhang X; Hu H; Ding LH; Yin D; Zhang YZ; Ni HF; Chen PS; Liu BC
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F514-22. PubMed ID: 25904701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
    Karsli Ceppioğlu S; Yurdun T; Canbakan M
    Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Klotho promoter methylation status and its prognostic value in ovarian cancer.
    Al-Zahrani MH; Yahya FM; Assidi M; Dallol A; Buhmeida A
    Mol Clin Oncol; 2021 Sep; 15(3):181. PubMed ID: 34277000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease.
    Onishi A; Sugiyama H; Kitagawa M; Yamanari T; Tanaka K; Ogawa-Akiyama A; Kano Y; Mise K; Tanabe K; Morinaga H; Kinomura M; Uchida HA; Wada J
    Dis Markers; 2019; 2019():5432453. PubMed ID: 31354889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
    Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
    Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic nicotine exposure reduces klotho expression and triggers different renal and hemodynamic responses in klotho-haploinsufficient mice.
    Coelho FO; Jorge LB; de Bragança Viciana AC; Sanches TR; Dos Santos F; Helou CMB; Irigoyen MC; Kuro-O M; Andrade L
    Am J Physiol Renal Physiol; 2018 May; 314(5):F992-F998. PubMed ID: 29363324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.
    Bigé N; Lévy PP; Callard P; Faintuch JM; Chigot V; Jousselin V; Ronco P; Boffa JJ
    BMC Nephrol; 2012 Oct; 13():139. PubMed ID: 23098365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Zhou H; Yang M; Jiang Z; Ding J; Di J; Cui L
    Am J Nephrol; 2018; 48(1):46-55. PubMed ID: 30048964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.